choline has been researched along with Dyslipidemia in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Dyslipidemia is an important modifiable risk factor." | 6.46 | The role of a new formulation of fenofibric acid in the treatment of mixed dyslipidemia in type 2 diabetes. ( Campbell, J; Mohiuddin, SM, 2010) |
| "Higher triglyceride and lower HDL levels statistically account for the association between BMI and myo-inositol, pointing toward a potentially critical role for dyslipidemia in the development of cerebral neurochemical alterations in obesity." | 3.79 | Dyslipidemia links obesity to early cerebral neurochemical alterations. ( Gonzales, MM; Haley, AP; Tanaka, H; Tarumi, T, 2013) |
| "Dyslipidemia is an important modifiable risk factor." | 2.46 | The role of a new formulation of fenofibric acid in the treatment of mixed dyslipidemia in type 2 diabetes. ( Campbell, J; Mohiuddin, SM, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haley, AP | 1 |
| Gonzales, MM | 1 |
| Tarumi, T | 1 |
| Tanaka, H | 1 |
| Campbell, J | 1 |
| Mohiuddin, SM | 1 |
1 review available for choline and Dyslipidemia
| Article | Year |
|---|---|
The role of a new formulation of fenofibric acid in the treatment of mixed dyslipidemia in type 2 diabetes.
Topics: Choline; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Dyslipidemias; Fenofibrate; Humans; H | 2010 |
1 other study available for choline and Dyslipidemia
| Article | Year |
|---|---|
Dyslipidemia links obesity to early cerebral neurochemical alterations.
Topics: Adult; Aspartic Acid; Blood Glucose; Blood Pressure; Body Mass Index; Brain; Brain Diseases; Cholest | 2013 |